glp-1 meal ideas for weight loss What to Eat on a Diet, According to a Dietitian GLP1 Meal Plan: What to

Now you understand its benefits and know the right supplementation strategies

All references FDA: Concerns with unapproved GLP-1 drugs used for weight loss NEJM (2023): Retatrutide Phase 2 trial in obesity Eli Lilly: Phase 2 retatrutide results published in NEJM Eli Lilly (Dec 2025): Phase 3 TRIUMPH-4 topline results announcement ClinicalTrials.gov: NCT05882045 (TRIUMPH-3) Drugs.com: Retatrutide status & timeline Lilly Trials: TRIUMPH-3 summary page

Epithalon Epithalon (Epitalon) is a synthetic tetrapeptide studied for its potential role in telomerase activation and cellular aging regulation

Safety Considerations and Future Outlook As with all pharmacotherapy for obesity and T2D, establishing cardiovascular safety and demonstrating improvements in meaningful clinical outcomes will be essential, particularly as cardiovascular outcome trials have not yet been completed with multi-agonists (although data are expected soon for tirzepatide: SURPASS-CVOT [T2D] in 2025

J Biol Chem 250:14221426 Ristoff E, Larsson A (2007) Inborn errors in the metabolism of glutathione

Pegylation enhances the peptides stability and circulating half-life, allowing prolonged biological activity compared to non-pegylated MGF